Corning Pharmaceutical Glass Solar PV Facility, New Jersey, USA

Corning Pharmaceutical Glass is a solar photovoltaic (PV) facility located in New Jersey, United States. With a capacity of 2.3 MW, it represents a small-scale renewable energy installation serving the pharmaceutical glass manufacturing sector. The facility is owned by CVI CleanCapital Solar 4 LLC and is currently operational. The plant operates under the regulatory framework of the United States, which includes the Inflation Reduction Act (IRA) and state-level Renewable Portfolio Standards (RPS). New Jersey's RPS targets 50% renewable energy by 2030, supporting solar PV deployment. The facility uses solar panels to convert sunlight into electricity, contributing to the state's clean energy goals. This solar installation helps reduce the carbon footprint of the pharmaceutical glass manufacturing process by providing on-site renewable energy. It also supports grid stability by generating electricity during peak sunlight hours. The facility's location in an industrial area minimizes land-use conflicts, and its small scale reduces visual impact.

The facility is located in New Jersey, a state with strong solar insolation suitable for PV generation. The region's industrial context means the solar panels are installed on existing structures or land, minimizing additional land-use impact. Solar PV has low environmental impact during operation, with no emissions or water use, though manufacturing and disposal of panels involve resource use. The facility supports local renewable energy targets and reduces reliance on fossil fuels.